12:00 AM
Jul 29, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Inovio preclinical data

In mice, Inovio's H7N9 SynCon universal influenza vaccine delivered with the company's electroporation system led to protection against sickness and death from challenge with...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >